According to Asia News' report on May 21st, Thailand's Minister of Public Health, Somsak Thepsutin, announced on Monday (20th) that marijuana will be reclassified as a Schedule 5 controlled substance within this year.
A survey conducted by the National Institute of Development Administration (NIDA Poll) in Thailand showed that 60.38% of respondents "completely agree" with the reclassification of marijuana as a drug, 15.27% "somewhat agree," 14.5% "completely disagree," 8.93% "strongly disagree," and 0.92% did not comment. Additionally, 46.95% of respondents believe that the government should not compensate individuals affected by the reclassification, 35.03% believe compensation should be given to marijuana growers and businesses, and 10.08% believe compensation should only be given to growers. The survey included 1310 individuals aged 15 and older nationwide and was conducted on May 14th and 15th.
According to a NIDA poll, 68.93% of respondents have never used marijuana, while 31.07% have used it at some point.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
